394 related articles for article (PubMed ID: 14983104)
1. Neurally mediated hypotension in systemic lupus erythematosus patients with fibromyalgia.
Tang S; Calkins H; Petri M
Rheumatology (Oxford); 2004 May; 43(5):609-14. PubMed ID: 14983104
[TBL] [Abstract][Full Text] [Related]
2. Fibromyalgia is a major contributor to quality of life in lupus.
Gladman DD; Urowitz MB; Gough J; MacKinnon A
J Rheumatol; 1997 Nov; 24(11):2145-8. PubMed ID: 9375874
[TBL] [Abstract][Full Text] [Related]
3. Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus.
Da Costa D; Dobkin PL; Fitzcharles MA; Fortin PR; Beaulieu A; Zummer M; Senécal JL; Goulet JR; Rich E; Choquette D; Clarke AE
J Rheumatol; 2000 Feb; 27(2):365-72. PubMed ID: 10685798
[TBL] [Abstract][Full Text] [Related]
4. Fatigue in lupus is not correlated with disease activity.
Wang B; Gladman DD; Urowitz MB
J Rheumatol; 1998 May; 25(5):892-5. PubMed ID: 9598886
[TBL] [Abstract][Full Text] [Related]
5. Number of fibromyalgia tender points is associated with health status in patients with systemic lupus erythematosus.
Akkasilpa S; Goldman D; Magder LS; Petri M
J Rheumatol; 2005 Jan; 32(1):48-50. PubMed ID: 15630724
[TBL] [Abstract][Full Text] [Related]
6. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
Mok CC; Ho LY; Cheung MY; Yu KL; To CH
Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
[TBL] [Abstract][Full Text] [Related]
8. Quality of life in systemic lupus erythematosus: a controlled study.
Abu-Shakra M; Mader R; Langevitz P; Friger M; Codish S; Neumann L; Buskila D
J Rheumatol; 1999 Feb; 26(2):306-9. PubMed ID: 9972963
[TBL] [Abstract][Full Text] [Related]
9. The impact of increased body mass index on systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA XLVI) [corrected].
Chaiamnuay S; Bertoli AM; Fernández M; Apte M; Vilá LM; Reveille JD; Alarcón GS;
J Clin Rheumatol; 2007 Jun; 13(3):128-33. PubMed ID: 17551377
[TBL] [Abstract][Full Text] [Related]
10. Association of coping responses with fibromyalgia tender points in patients with systemic lupus erythematosus.
Akkasilpa S; Minor M; Goldman D; Magder LS; Petri M
J Rheumatol; 2000 Mar; 27(3):671-4. PubMed ID: 10743806
[TBL] [Abstract][Full Text] [Related]
11. EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia.
Wolfe F; Michaud K; Li T; Katz RS
J Rheumatol; 2010 Feb; 37(2):296-304. PubMed ID: 20032098
[TBL] [Abstract][Full Text] [Related]
12. Work disability in systemic lupus erythematosus is prevalent and associated with socio-demographic and disease related factors.
Baker K; Pope J; Fortin P; Silverman E; Peschken C; ;
Lupus; 2009 Dec; 18(14):1281-8. PubMed ID: 19854811
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life in portuguese SLE patients: an outcome measure independent of disease activity and cumulative damage.
Duarte C; Abreu P; Couto M; Vaz C; Malcata A; Inês L
Acta Reumatol Port; 2010; 35(1):30-5. PubMed ID: 20518146
[TBL] [Abstract][Full Text] [Related]
14. [The association of fibromyalgia and systemic lupus erythematosus change the presentation and severity of both diseases?].
de Araújo AL; Paliares IC; de Araújo MI; Novo NF; Cadaval RA; Martinez JE
Rev Bras Reumatol; 2015; 55(1):37-42. PubMed ID: 25435167
[TBL] [Abstract][Full Text] [Related]
15. Irritable bowel syndrome-type symptoms in female patients with mild systemic lupus erythematosus: frequency, related factors and quality of life.
García Carrasco M; Mendoza Pinto C; López Colombo A; Méndez Martínez S; Andari Sawaya R; Muñoz Guarneros M; Vázquez De Lara L; Lescas Hernández M; Montiel Jarquín A; Ramos Álvarez G; Schmulson M
Neurogastroenterol Motil; 2013 Dec; 25(12):958-66. PubMed ID: 24112121
[TBL] [Abstract][Full Text] [Related]
16. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus.
Stoll T; Gordon C; Seifert B; Richardson K; Malik J; Bacon PA; Isenberg DA
J Rheumatol; 1997 Aug; 24(8):1608-14. PubMed ID: 9263159
[TBL] [Abstract][Full Text] [Related]
17. Self-reported flaring varies during the menstrual cycle in systemic lupus erythematosus compared with rheumatoid arthritis and fibromyalgia.
Colangelo K; Haig S; Bonner A; Zelenietz C; Pope J
Rheumatology (Oxford); 2011 Apr; 50(4):703-8. PubMed ID: 21115463
[TBL] [Abstract][Full Text] [Related]
18. Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices.
Moore AD; Clarke AE; Danoff DS; Joseph L; Bélisle P; Neville C; Fortin PR
J Rheumatol; 1999 Jun; 26(6):1285-90. PubMed ID: 10381044
[TBL] [Abstract][Full Text] [Related]
19. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
